Biochemical analysis further revealed that semaglutide significantly lowered AST, TG, and TC, although with a slight increase in serum ALT levels (Fig.5-E, F, G, H)
M., Bryant, A., Ramos, D., et al
individuals with diabetes from 2015 to 2019, lower GLP-1 use was seen among Asian, Black, and Hispanic, compared with White, individuals and among those living in lower versus higher income households [229]
The concern about hyperglycemia is mitigated by simultaneous GLP-1 receptor activation, which enhances insulin secretion and suppresses hepatic glucose production through different pathways
Conclusion A well-structured GLP-1 telemedicine program can significantly boost clinic revenue when paired with smart pricing, retention strategies, and nationwide scalability